163 related articles for article (PubMed ID: 34323589)
1. Gadoteridol-enhanced MRI of the breast: can contrast agent injection rate impact background parenchymal enhancement?
Marzocca F; Moffa G; Landi VN; Panzironi G; Kirchin MA; Pediconi F; Galati F
Acta Radiol; 2022 Sep; 63(9):1173-1179. PubMed ID: 34323589
[TBL] [Abstract][Full Text] [Related]
2. Effects of gadobutrol on background parenchymal enhancement and differential diagnosis between benign and malignant lesions in dynamic magnetic resonance imaging of the breast.
Tozaki M; Yabuuchi H; Goto M; Sasaki M; Kubota K; Nakahara H
Breast Cancer; 2021 Jul; 28(4):927-936. PubMed ID: 33625722
[TBL] [Abstract][Full Text] [Related]
3. Does breast MRI background parenchymal enhancement indicate metabolic activity? Qualitative and 3D quantitative computer imaging analysis.
Mema E; Mango VL; Guo X; Karcich J; Yeh R; Wynn RT; Zhao B; Ha RS
J Magn Reson Imaging; 2018 Mar; 47(3):753-759. PubMed ID: 28646614
[TBL] [Abstract][Full Text] [Related]
4. Impact of background parenchymal enhancement levels on the diagnosis of contrast-enhanced digital mammography in evaluations of breast cancer: comparison with contrast-enhanced breast MRI.
Yuen S; Monzawa S; Gose A; Yanai S; Yata Y; Matsumoto H; Ichinose Y; Tashiro T; Yamagami K
Breast Cancer; 2022 Jul; 29(4):677-687. PubMed ID: 35220511
[TBL] [Abstract][Full Text] [Related]
5. Comparison between qualitative and quantitative assessment of background parenchymal enhancement on breast MRI.
Pujara AC; Mikheev A; Rusinek H; Gao Y; Chhor C; Pysarenko K; Rallapalli H; Walczyk J; Moccaldi M; Babb JS; Melsaether AN
J Magn Reson Imaging; 2018 Jun; 47(6):1685-1691. PubMed ID: 29140576
[TBL] [Abstract][Full Text] [Related]
6. Background parenchymal enhancement assessment: Inter- and intra-rater reliability across breast MRI sequences.
Bignotti B; Calabrese M; Signori A; Tosto S; Valdora F; Tagliafico A; Durando M; Mariscotti G
Eur J Radiol; 2019 May; 114():57-61. PubMed ID: 31005177
[TBL] [Abstract][Full Text] [Related]
7. Association of Clinical Factors and Degree of Early Background Parenchymal Enhancement on Contrast-Enhanced Mammography.
Wang S; Sun Y; You C; Jiang T; Yang M; Shen X; Qian M; Duan S; Lynn HS; Li R; Gu Y
AJR Am J Roentgenol; 2023 Jul; 221(1):45-55. PubMed ID: 36695647
[No Abstract] [Full Text] [Related]
8. Breast MRI during Neoadjuvant Chemotherapy: Lack of Background Parenchymal Enhancement Suppression and Inferior Treatment Response.
Onishi N; Li W; Newitt DC; Harnish RJ; Strand F; Nguyen AA; Arasu VA; Gibbs J; Jones EF; Wilmes LJ; Kornak J; Joe BN; Price ER; Ojeda-Fournier H; Eghtedari M; Zamora KW; Woodard S; Umphrey HR; Nelson MT; Church AL; Bolan PJ; Kuritza T; Ward K; Morley K; Wolverton D; Fountain K; Lopez Paniagua D; Hardesty L; Brandt KR; McDonald ES; Rosen M; Kontos D; Abe H; Sheth D; Crane E; Dillis C; Sheth P; Hovanessian-Larsen L; Bang DH; Porter B; Oh KY; Jafarian N; Tudorica LA; Niell B; Drukteinis J; Newell MS; Giurescu ME; Berman E; Lehman CD; Partridge SC; Fitzpatrick KA; Borders MH; Yang WT; Dogan B; Goudreau SH; Chenevert T; Yau C; DeMichele A; Berry DA; Esserman LJ; Hylton NM
Radiology; 2021 Nov; 301(2):295-308. PubMed ID: 34427465
[TBL] [Abstract][Full Text] [Related]
9. Role of dynamic contrast-enhanced MRI in evaluating the association between contralateral parenchymal enhancement and survival outcome in ER-positive, HER2-negative, node-negative invasive breast cancer.
Shin GW; Zhang Y; Kim MJ; Su MY; Kim EK; Moon HJ; Yoon JH; Park VY
J Magn Reson Imaging; 2018 Dec; 48(6):1678-1689. PubMed ID: 29734483
[TBL] [Abstract][Full Text] [Related]
10. Breast Background Parenchymal Enhancement on Screening Magnetic Resonance Imaging in Women Who Received Chest Radiotherapy for Childhood Hodgkin's Lymphoma.
Zeng L; Lo G; Moshonov H; Liang J; Hodgson D; Crystal P
Acad Radiol; 2016 Feb; 23(2):168-75. PubMed ID: 26546383
[TBL] [Abstract][Full Text] [Related]
11. Comparison of contrast enhancement and diffusion-weighted magnetic resonance imaging in healthy and cancerous breast tissue.
Cho GY; Moy L; Kim SG; Klautau Leite AP; Baete SH; Babb JS; Sodickson DK; Sigmund EE
Eur J Radiol; 2015 Oct; 84(10):1888-93. PubMed ID: 26220915
[TBL] [Abstract][Full Text] [Related]
12. Background parenchymal enhancement: is it just an innocent effect of estrogen on the breast?
Arslan G; Çelik L; Çubuk R; Çelik L; Atasoy MM
Diagn Interv Radiol; 2017; 23(6):414-419. PubMed ID: 29097344
[TBL] [Abstract][Full Text] [Related]
13. Background parenchymal enhancement at breast MR imaging: normal patterns, diagnostic challenges, and potential for false-positive and false-negative interpretation.
Giess CS; Yeh ED; Raza S; Birdwell RL
Radiographics; 2014; 34(1):234-47. PubMed ID: 24428293
[TBL] [Abstract][Full Text] [Related]
14. Breast MRI background parenchymal enhancement as an imaging bridge to molecular cancer sub-type.
Dilorenzo G; Telegrafo M; La Forgia D; Stabile Ianora AA; Moschetta M
Eur J Radiol; 2019 Apr; 113():148-152. PubMed ID: 30927939
[TBL] [Abstract][Full Text] [Related]
15. Background parenchymal enhancement and its effect on lesion detectability in ultrafast dynamic contrast-enhanced MRI.
Honda M; Kataoka M; Iima M; Miyake KK; Ohashi A; Kishimoto AO; Ota R; Nickel MD; Toi M; Togashi K
Eur J Radiol; 2020 Aug; 129():108984. PubMed ID: 32534350
[TBL] [Abstract][Full Text] [Related]
16. Effect of Background Parenchymal Enhancement on Pre-Operative Breast Magnetic Resonance Imaging: How It Affects Interpretation and the Role of Second-Look Ultrasound in Patient Management.
Kim SY; Lee HS; Kim EK; Kim MJ; Moon HJ; Yoon JH
Ultrasound Med Biol; 2016 Dec; 42(12):2766-2774. PubMed ID: 27658753
[TBL] [Abstract][Full Text] [Related]
17. Quantitative evaluation of background parenchymal enhancement (BPE) on breast MRI. A feasibility study with a semi-automatic and automatic software compared to observer-based scores.
Tagliafico A; Bignotti B; Tagliafico G; Tosto S; Signori A; Calabrese M
Br J Radiol; 2015; 88(1056):20150417. PubMed ID: 26462852
[TBL] [Abstract][Full Text] [Related]
18. Breast MRI Background Parenchymal Enhancement Categorization Using Deep Learning: Outperforming the Radiologist.
Eskreis-Winkler S; Sutton EJ; D'Alessio D; Gallagher K; Saphier N; Stember J; Martinez DF; Morris EA; Pinker K
J Magn Reson Imaging; 2022 Oct; 56(4):1068-1076. PubMed ID: 35167152
[TBL] [Abstract][Full Text] [Related]
19. Machine learning-based prediction of future breast cancer using algorithmically measured background parenchymal enhancement on high-risk screening MRI.
Saha A; Grimm LJ; Ghate SV; Kim CE; Soo MS; Yoon SC; Mazurowski MA
J Magn Reson Imaging; 2019 Aug; 50(2):456-464. PubMed ID: 30648316
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of background parenchymal enhancement in breast contrast-enhanced ultrasound with Sonazoid
Haga M; Hirai T; Nakai T; Kobayashi T; Nakamura T; Marugami A; Ito T; Takewa M; Marugami N; Kichikawa K
J Med Ultrason (2001); 2020 Oct; 47(4):591-601. PubMed ID: 32989596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
